Inverness Counsel LLC Eli Lilly & CO Transaction History

Inverness Counsel LLC

$1.8 Billion
Q3 2022

A detailed history of Inverness Counsel LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Inverness Counsel LLC holds 1,739 shares of LLY stock, worth $1.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,739

Previous 1,688 3.02%

Holding current value

$1.3 Million

Previous $547,000 2.74%

% of portfolio

0.03%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	BUY	$296.48 - $337.87 $15,120 - $17,231	51 Added 3.02%	1,739 $562,000
Q2 2022 Jul 20, 2022	SELL	$278.73 - $327.27 $22,298 - $26,181	-80 Reduced 4.52%	1,688 $547,000
Q1 2022 May 05, 2022	BUY	$234.69 - $291.66 $2,816 - $3,499	12 Added 0.68%	1,768 $506,000
Q4 2021 Feb 07, 2022	SELL	$224.85 - $279.04 $2,698 - $3,348	-12 Reduced 0.68%	1,756 $485,000
Q3 2021 Nov 02, 2021	BUY	$221.6 - $272.71 $2,659 - $3,272	12 Added 0.68%	1,768 $408,000
Q1 2021 May 04, 2021	SELL	$164.32 - $212.72 $32,864 - $42,544	-200 Reduced 10.22%	1,756 $328,000
Q2 2020 Aug 10, 2020	SELL	$136.42 - $164.18 $23,737 - $28,567	-174 Reduced 8.17%	1,956 $321,000
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $135,089 - $146,942	-1,265 Reduced 37.26%	2,130 $238,000
Q2 2019 Aug 07, 2019	SELL	$110.79 - $129.32 $52,625 - $61,427	-475 Reduced 12.27%	3,395 $376,000
Q1 2019 May 09, 2019	SELL	$111.31 - $131.02 $2.9 Million - $3.41 Million	-26,040 Reduced 87.06%	3,870 $502,000
Q4 2018 Jan 29, 2019	BUY	$105.9 - $118.64 $2.89 Million - $3.23 Million	27,255 Added 1026.55%	29,910 $3.46 Million
Q3 2018 Oct 30, 2018	BUY	$85.86 - $107.31 $26,530 - $33,158	309 Added 13.17%	2,655 $285,000
Q2 2018 Aug 02, 2018	BUY	$75.7 - $86.88 $177,592 - $203,820	2,346 New	2,346 $200,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inverness Counsel LLC , based on Form 13F filings with the SEC.

News

Stay updated on Inverness Counsel LLC with notifications on news.

Account

Inverness Counsel LLC Eli Lilly & CO Transaction History